IgG4-Related Disease
IgG4-related disease (IgG4-RD) is an immune-mediated condition characterized by elevated levels of IgG4 antibodies, leading to inflammation and damage in various organs, such as the pancreas, salivary glands, and lymph nodes.
IgG4-Related Disease: Abatacept Treatment Study
We are investigating whether abatacept can help reduce the risk of disease recurrence in people with IgG4-related disease. This study aims to provide insights into a new treatment option for managing this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have active IgG4-related disease or have you had a relapse with an IgG4-RD RI greater than 2?
- Are you pregnant or breastfeeding?
- Have you had any type of cancer in the last 5 years?
- Is your serum creatinine level above 2.0 mg/dL?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Ospedale San Raffaele S.r.l.
Immunologia, Reumatologia, Allergologia e Malattie Rare
Vimodrone, Italy
Sponsor: Ospedale San Raffaele S.r.l.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.